Skip to main content
. 2017 Jun 28;8(38):63177–63186. doi: 10.18632/oncotarget.18725

Table 4. Spearman correlation between DFX Ctrough, ductopenia ratio, and MTIC versus clinical variables.

Patients, n = 42 DFX Ctrough,μg/mL Ductopenia,ratio† MTIC,μmol/g
r p r p r p
DFX treatment duration (days) −0.6932 <0.0001 0.4299 0.0044 0.6954 <0.0001
DFX Ctrough (μg/mL) - - −0.4301 0.0044 −0.9159 <0.0001
Ferritin (ng/mL) −0.1787 0.2573 −0.2334 0.1369 0.2762 0.0766
Organs with IO (n) 0.0900 0.5706 −0.4059 0.0076 0.9264 <0.0001
MTIC (μmol/g) −0.9159 <0.0001 0.4649 0.0019 - -
Neutrophil (count/μL) −0.4203 0.0056 0.3451 0.0252 0.4345 0.0040
Hemoglobin (g/dL) −0.3031 0.0510 0.2801 0.0723 0.3216 0.0378
Platelets (×103/μL) −0.3680 0.0165 0.2340 0.1357 0.3296 0.0330
AST (U/L) 0.4412 0.0034 −0.4725 0.0016 −0.4168 0.0060
ALT (U/L) 0.4005 0.0086 −0.3660 0.0171 −0.3869 0.0114
Blood total bilirubin (mg/dL) 0.5960 <0.0001 −0.3532 0.0217 −0.3768 0.0139
Blood direct bilirubin (mg/dL) 0.7433 <0.0001 −0.4707 0.0016 −0.5231 0.0004
Clearance creatinine (mL/min/m2) −0.7196 <0.0001 0.5223 0.0004 0.6729 <0.0001

DFX, deferasirox; MTIC, mean tissue iron concentration; IO, iron overload; AST, aspartate aminotransferase; ALT, alanine aminotransferase.

†Ductopenia is expressed as the ratio of the number of interlobular bile ducts to number of portal tracts.